Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone?

Ashaka Patel, Premal Patel, Joshua Bitran, Ranjith Ramasamy

Research output: Contribution to journalReview article

Abstract

Serum testosterone values vary considerably with little correlation to intratesticular testosterone (ITT). ITT is approximately ~100 times that of serum testosterone and is critical for spermatogenesis. Unfortunately, the only method to accurately measure ITT is invasive testicular aspiration and therefore is not performed routinely. The identification of a serum biomarker for ITT would allow serial monitoring during hormonal manipulation and the ability to assess the effectiveness of a male contraceptive agent. Prior studies have evaluated several serum biomarkers for their ability to accurately reflect ITT with data supporting 17-hydroxyprogesterone (17-OHP) and insulin-like factor 3 (INSL3) as a potential marker. Because evaluation of serum 17-OHP is readily available through commercial laboratories, in this review, we present the evidence for 17-OHP and how it can play a pivotal role in the management of male infertility.

Original languageEnglish (US)
Pages (from-to)S58-S63
JournalTranslational Andrology and Urology
Volume8
DOIs
StatePublished - Jan 1 2019

Fingerprint

17-alpha-Hydroxyprogesterone
Testosterone
Insulin
Serum
Biomarkers
Male Contraceptive Agents
Male Infertility
Spermatogenesis

Keywords

  • 17-hydroxyprogesterone (17-OHP)
  • Biomarker
  • Infertility
  • Insulin-like factor 3 (INSL3)
  • Intratesticular testosterone (ITT)

ASJC Scopus subject areas

  • Reproductive Medicine
  • Urology

Cite this

Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone? / Patel, Ashaka; Patel, Premal; Bitran, Joshua; Ramasamy, Ranjith.

In: Translational Andrology and Urology, Vol. 8, 01.01.2019, p. S58-S63.

Research output: Contribution to journalReview article

@article{6cefac5d45474ec59d43fbbefccd5cd6,
title = "Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone?",
abstract = "Serum testosterone values vary considerably with little correlation to intratesticular testosterone (ITT). ITT is approximately ~100 times that of serum testosterone and is critical for spermatogenesis. Unfortunately, the only method to accurately measure ITT is invasive testicular aspiration and therefore is not performed routinely. The identification of a serum biomarker for ITT would allow serial monitoring during hormonal manipulation and the ability to assess the effectiveness of a male contraceptive agent. Prior studies have evaluated several serum biomarkers for their ability to accurately reflect ITT with data supporting 17-hydroxyprogesterone (17-OHP) and insulin-like factor 3 (INSL3) as a potential marker. Because evaluation of serum 17-OHP is readily available through commercial laboratories, in this review, we present the evidence for 17-OHP and how it can play a pivotal role in the management of male infertility.",
keywords = "17-hydroxyprogesterone (17-OHP), Biomarker, Infertility, Insulin-like factor 3 (INSL3), Intratesticular testosterone (ITT)",
author = "Ashaka Patel and Premal Patel and Joshua Bitran and Ranjith Ramasamy",
year = "2019",
month = "1",
day = "1",
doi = "10.21037/tau.2019.01.16",
language = "English (US)",
volume = "8",
pages = "S58--S63",
journal = "Translational Andrology and Urology",
issn = "2223-4683",
publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone?

AU - Patel, Ashaka

AU - Patel, Premal

AU - Bitran, Joshua

AU - Ramasamy, Ranjith

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Serum testosterone values vary considerably with little correlation to intratesticular testosterone (ITT). ITT is approximately ~100 times that of serum testosterone and is critical for spermatogenesis. Unfortunately, the only method to accurately measure ITT is invasive testicular aspiration and therefore is not performed routinely. The identification of a serum biomarker for ITT would allow serial monitoring during hormonal manipulation and the ability to assess the effectiveness of a male contraceptive agent. Prior studies have evaluated several serum biomarkers for their ability to accurately reflect ITT with data supporting 17-hydroxyprogesterone (17-OHP) and insulin-like factor 3 (INSL3) as a potential marker. Because evaluation of serum 17-OHP is readily available through commercial laboratories, in this review, we present the evidence for 17-OHP and how it can play a pivotal role in the management of male infertility.

AB - Serum testosterone values vary considerably with little correlation to intratesticular testosterone (ITT). ITT is approximately ~100 times that of serum testosterone and is critical for spermatogenesis. Unfortunately, the only method to accurately measure ITT is invasive testicular aspiration and therefore is not performed routinely. The identification of a serum biomarker for ITT would allow serial monitoring during hormonal manipulation and the ability to assess the effectiveness of a male contraceptive agent. Prior studies have evaluated several serum biomarkers for their ability to accurately reflect ITT with data supporting 17-hydroxyprogesterone (17-OHP) and insulin-like factor 3 (INSL3) as a potential marker. Because evaluation of serum 17-OHP is readily available through commercial laboratories, in this review, we present the evidence for 17-OHP and how it can play a pivotal role in the management of male infertility.

KW - 17-hydroxyprogesterone (17-OHP)

KW - Biomarker

KW - Infertility

KW - Insulin-like factor 3 (INSL3)

KW - Intratesticular testosterone (ITT)

UR - http://www.scopus.com/inward/record.url?scp=85068260306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068260306&partnerID=8YFLogxK

U2 - 10.21037/tau.2019.01.16

DO - 10.21037/tau.2019.01.16

M3 - Review article

AN - SCOPUS:85068260306

VL - 8

SP - S58-S63

JO - Translational Andrology and Urology

JF - Translational Andrology and Urology

SN - 2223-4683

ER -